全文获取类型
收费全文 | 85229篇 |
免费 | 10108篇 |
国内免费 | 4828篇 |
专业分类
耳鼻咽喉 | 929篇 |
儿科学 | 1482篇 |
妇产科学 | 723篇 |
基础医学 | 4788篇 |
口腔科学 | 1862篇 |
临床医学 | 11381篇 |
内科学 | 8505篇 |
皮肤病学 | 1157篇 |
神经病学 | 2320篇 |
特种医学 | 3624篇 |
外国民族医学 | 1篇 |
外科学 | 7424篇 |
综合类 | 21509篇 |
现状与发展 | 13篇 |
预防医学 | 11573篇 |
眼科学 | 999篇 |
药学 | 8967篇 |
119篇 | |
中国医学 | 8443篇 |
肿瘤学 | 4346篇 |
出版年
2024年 | 487篇 |
2023年 | 1418篇 |
2022年 | 2753篇 |
2021年 | 3526篇 |
2020年 | 3233篇 |
2019年 | 1709篇 |
2018年 | 2167篇 |
2017年 | 2746篇 |
2016年 | 2238篇 |
2015年 | 3792篇 |
2014年 | 4681篇 |
2013年 | 6066篇 |
2012年 | 7453篇 |
2011年 | 7773篇 |
2010年 | 7252篇 |
2009年 | 6625篇 |
2008年 | 6280篇 |
2007年 | 6005篇 |
2006年 | 5291篇 |
2005年 | 4127篇 |
2004年 | 2894篇 |
2003年 | 2355篇 |
2002年 | 1883篇 |
2001年 | 1804篇 |
2000年 | 1208篇 |
1999年 | 606篇 |
1998年 | 407篇 |
1997年 | 416篇 |
1996年 | 405篇 |
1995年 | 330篇 |
1994年 | 260篇 |
1993年 | 248篇 |
1992年 | 157篇 |
1991年 | 127篇 |
1990年 | 118篇 |
1989年 | 147篇 |
1988年 | 126篇 |
1987年 | 115篇 |
1986年 | 112篇 |
1985年 | 107篇 |
1984年 | 78篇 |
1983年 | 82篇 |
1982年 | 64篇 |
1981年 | 67篇 |
1980年 | 45篇 |
1979年 | 28篇 |
1978年 | 25篇 |
1977年 | 39篇 |
1976年 | 33篇 |
1954年 | 20篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
上颌阻生尖牙的临床诊断与治疗 总被引:2,自引:0,他引:2
目的:对阻生上颌尖牙的病因、临床检查、诊断及其相应的治疗进行了临床研究。方法:选取57例上颌尖牙阻生患者,通过病史询问、临床检查、X线片和模型测量的综合分析,从临床角度对阻生牙进行了诊断分类,采用不同的方法进行了矫治,并对矫治效果进行了评估。结果:采取适宜有效的治疗办法,均取得了满意的治疗效果,牙周膜愈合成功率达100%,活髓牙成功率达93.6%,牙龈形态良好者达89.4%。结论:尖牙阻生情况各异,治疗方法多样,根据临床分类选择合适的治疗方法,是矫治成功的关键。 相似文献
35.
肺癌组织中血管内皮生长因子受体Flt1及KDR的表达及其与肿瘤转移和预后的关系 总被引:1,自引:1,他引:0
①目的 探讨肺癌中血管内皮生长因子受体Flt1、KDR的表达与其转移及预后的关系。②方法 应用免疫组织化学PowerVisionTM PV90 0 0法 ,测定 75例肺癌标本中Flt1、KDR的表达。③结果 肺癌组织中Flt1、KDR的表达较为广泛 ,主要位于肿瘤细胞胞浆及胞膜上 ,纤维母细胞和血管内皮细胞胞浆中亦有表达。Flt1、KDR在肿瘤细胞中的阳性率均显著高于在间质纤维母细胞中的表达 (χ2 =6 .0 7、5 .88,P <0 .0 5 )。肿瘤细胞及纤维母细胞中该两种受体的阳性率在不同年龄、不同性别及不同病理类型、不同病理分级之间差异均无显著性 (χ2 =0 .0 1~4 .84 ,P >0 .0 5 ;P =0 .2 9~ 0 .79)。肿瘤细胞中Flt1、KDR的阳性表达率在 3组不同大小的肿瘤间差异均有显著性(χ2 =1 0 .35、7.2 9,P <0 .0 5 ) ,而纤维母细胞中差异均无显著性 (χ2 =2 .86、2 .5 6 ,P >0 .0 5 ) ;肿瘤细胞及纤维母细胞中Flt1、KDR的阳性率在淋巴结有、无转移两组间的差异均有显著性 (χ2 =4 .72~ 9.32 ,P <0 .0 5 ) ,在 3组不同术后生存时间病人间亦均有显著性差异 (χ2 =8.81~ 1 9.1 9,P <0 .0 5 )。肿瘤细胞中Flt1、KDR的表达呈极显著性正相关 (r =0 .4 4 ,P <0 .0 1 )。④结论 肺癌的生长主要依赖自分泌机制 ,联合检测Flt1、KDR可能对肺癌转移 相似文献
36.
Mark Foord BA MA Julie Savory BA MA MCiH Dianne Sodhi BA MA MCiH 《Health & social care in the community》2004,12(2):126-133
This paper reflects on a research project funded by a consortium of leading sheltered housing (SH) providers and their regulatory body, the Housing Corporation. The project aimed to ascertain which aspects of SH older people perceived to be central to their satisfaction and the methods they judged most appropriate to measuring this. We outline key policy developments of importance to SH (specifically the development of performance measurement regimes), and changes in the nature of SH, which are driving providers to re‐evaluate how they measure user satisfaction. We discuss the aims of the project, our methodology and findings, and conclude by raising critical questions about the process of measuring satisfaction within an increasingly managerialised housing system. We argue that this favours standardised methods of information gathering (such as questionnaires) rather than engage with clients in order to develop methods and systems capable of eliciting qualitative issues of concern to them. Our conclusions are, we believe, applicable to health and social care provision, where similar tensions exist around performance measurement and user satisfaction. 相似文献
37.
38.
Jonas T. Johnson MD Editor John K. Niparko MD Editor-in-Chief Paul A. Levine MD Editor David W. Kennedy MD Editor Pete Weber MD Editor-in-Chief Randal S. Weber MD Editor Michael S. Benninger MD Past Editor in Chief Richard M. Rosenfeld MD MPH Editor in Chief Robert J. Ruben MD Editor in Chief Richard J.H. Smith MD Editor in Chief Robert Thayer Sataloff MD DMA Editor in Chief Neil Weir MA FRCS Editor Emeritus 《Otolaryngology--head and neck surgery》2006,135(6):829-830
39.
40.
Kiyoshi Hashizume Kazuo Ichikawa Satoru Suzuki Teiji Takeda Keishi Yamauchi Mutsuhiro Kobayashi Xiao-Yun MA 《Journal of bone and mineral metabolism》1992,10(2):39-49
Calorie restriction is important in managing patients with maturity onset diabetes mellitus (NIDDM). The effect of such restriction
on calcium metabolism is not known. The objective of this study was to determine whether patients on calorie restricted diets
would show any modification of parathyroid hormone (PTH) and calcitonin (CTN).
The serum levels of PTH and CTN were measured by radioimmunoassays in 269 patients with NIDDM. The patients were divided into
two groups depending on the intake of calorie, and PTH and CTN were monitored for 2 years. Plasma levels of vitamin D were
measured by competitive protein binding assays before and after each program.
The level of PTH (520.8±266.0 pg/ml) (mean±S.D.) was significantly (P<0.01) higher in 109 diabetic patients whose calorie intake was restricted for 2 years (diet (D) group) as compared with that
(256.6±103.8 pg/ml) of 160 diabetic patients whose calorie intake was not restricted (non-diet (ND) group). The daily oral
calcium intake of the two groups did not differ significantly. We found no significant difference in the serum PTH level in
the ND groupVS. normal control subjects (248.8±98.4, N=78). The serum calcium concentration and the amount of calcium excreted in urine
were slightly but significantly (P<0.01) lower in the D than in the ND group. The rate of tubular reabsorption of phosphate (% TRP) was significantly lower
in the D group than that in the ND group (P<0.01). The serum CTN level was significantly (P<0.01) lower in the D group (33.9±11.3 pg/ml) than in the ND group (64.9±21.2 pg/ml) 2 years after each treatment. The plasma
1,25-(OH)2-vitamin D level was significantly (P<0.01) lower in the D group (22.2±6.6 pg/ml) than in the ND group (50.6±4.2 pg/ml). When
the restriction of calorie intake in the D group was canceled, their PTH levels decreased, which was accompanied by increase
in the 1,25-(OH)2-vitamin D levels, whereas their CTN levels were unchanged.
These observations suggested that a restricted calorie intake is a risk factor for secondary hyperparathyroidism as well as
for a low serum level of CTN in patients with NIDDM. 相似文献